International Stem Cell CORP (ISCO) stock
ISCOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.28+0.00 (+0.89%)
Close on Oct 19, 2026Market cap $2.27MP/E –Yield –
International Stem Cell revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
International Stem Cell's revenue for the twelve months ending Jun 30, 2026 was $9.51M, up 3.4% year over year. For fiscal 2025 it was $9.10M, up 0.2% from the year before. Over ten years it grew 1.9% a year on average. The highest annual figure on record is $11.09M in fiscal 2018.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.10M | +0.2% |
| FY2024 | Dec 31, 2024 | $9.09M | +16.6% |
| FY2023 | Dec 31, 2023 | $7.79M | -4.8% |
| FY2022 | Dec 31, 2022 | $8.18M | +14.0% |
| FY2021 | Dec 31, 2021 | $7.18M | +0.7% |
| FY2020 | Dec 31, 2020 | $7.13M | -24.7% |
| FY2019 | Dec 31, 2019 | $9.47M | -14.6% |
| FY2018 | Dec 31, 2018 | $11.09M | +48.7% |
| FY2017 | Dec 31, 2017 | $7.46M | +4.1% |
| FY2016 | Dec 31, 2016 | $7.17M | -5.1% |
| FY2015 | Dec 31, 2015 | $7.55M | +7.6% |
| FY2014 | Dec 31, 2014 | $7.02M | +14.2% |
| FY2013 | Dec 31, 2013 | $6.15M | +34.6% |
| FY2012 | Dec 31, 2012 | $4.57M | +0.8% |
| FY2011 | Dec 31, 2011 | $4.53M | +189.0% |
| FY2010 | Dec 31, 2010 | $1.57M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.68M | +9.3% |
| Q1 FY2026 | Mar 31, 2026 | $2.32M | +8.7% |
| Q4 FY2025 | Dec 31, 2025 | $2.16M | -11.9% |
| Q3 FY2025 | Sep 30, 2025 | $2.37M | +8.7% |
| Q2 FY2025 | Jun 30, 2025 | $2.45M | +5.0% |
| Q1 FY2025 | Mar 31, 2025 | $2.13M | 0.0% |
| Q4 FY2024 | Dec 31, 2024 | $2.45M | +29.5% |
| Q3 FY2024 | Sep 30, 2024 | $2.18M | +10.4% |
| Q2 FY2024 | Jun 30, 2024 | $2.33M | +26.6% |
| Q1 FY2024 | Mar 31, 2024 | $2.13M | +2.1% |
| Q4 FY2023 | Dec 31, 2023 | $1.89M | -22.3% |
| Q3 FY2023 | Sep 30, 2023 | $1.97M | +15.9% |
| Q2 FY2023 | Jun 30, 2023 | $1.84M | -9.2% |
| Q1 FY2023 | Mar 31, 2023 | $2.09M | +3.3% |
| Q4 FY2022 | Dec 31, 2022 | $2.43M | +32.6% |
| Q3 FY2022 | Sep 30, 2022 | $1.70M | +2.7% |
| Q2 FY2022 | Jun 30, 2022 | $2.03M | +37.3% |
| Q1 FY2022 | Mar 31, 2022 | $2.02M | +36.4% |
| Q2 FY2021 | Jun 30, 2021 | $1.83M | +1.2% |
| Q1 FY2021 | Mar 31, 2021 | $1.66M | -29.7% |
| Q4 FY2020 | Dec 31, 2020 | $1.48M | -48.0% |
| Q3 FY2020 | Sep 30, 2020 | $1.48M | -29.3% |
| Q2 FY2020 | Jun 30, 2020 | $1.81M | -21.9% |
| Q1 FY2020 | Mar 31, 2020 | $2.36M | +6.4% |
| Q4 FY2019 | Dec 31, 2019 | $2.84M | +27.6% |
| Q3 FY2019 | Sep 30, 2019 | $2.10M | -34.4% |
| Q2 FY2019 | Jun 30, 2019 | $2.32M | -23.6% |
| Q1 FY2019 | Mar 31, 2019 | $2.22M | -15.8% |
| Q4 FY2018 | Dec 31, 2018 | $2.22M | +20.7% |
| Q3 FY2018 | Sep 30, 2018 | $3.20M | +73.0% |
| Q2 FY2018 | Jun 30, 2018 | $3.04M | +72.4% |
| Q1 FY2018 | Mar 31, 2018 | $2.63M | +31.3% |
| Q4 FY2017 | Dec 31, 2017 | $1.84M | +9.0% |
| Q3 FY2017 | Sep 30, 2017 | $1.85M | -4.9% |
| Q2 FY2017 | Jun 30, 2017 | $1.76M | -8.0% |
| Q1 FY2017 | Mar 31, 2017 | $2.01M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.69M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.94M | – |
| Q2 FY2016 | Jun 30, 2016 | $1.92M | – |
See a number that looks wrong?